Literature DB >> 2235809

Clinical hyperthyroidism due to non-neoplastic inappropriate thyrotrophin secretion.

A W Chan1, I A MacFarlane, C van Heyningen, P M Foy.   

Abstract

We report a case of hyperthyroidism due to inappropriate thyrotrophin (TSH) secretion in a patient with selective pituitary resistance to thyroid hormone action. Symptoms of hyperthyroidism in patients with this disorder are usually mild, implying some peripheral tissue resistance to the metabolic effects of thyroid hormone. Our patient had unusually severe symptoms, including marked weight loss and cardiac arrythmias which required carbimazole and beta-blocker therapy for control. Somatostatin was ineffective in suppressing TSH secretion. The introduction of sensitive thyrotrophin assays should facilitate the accurate diagnosis of TSH-induced hyperthyroidism and avoid inappropriate treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2235809      PMCID: PMC2426904          DOI: 10.1136/pgmj.66.779.743

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  17 in total

1.  Endocrine and morphologic studies of pituitary adenomas secondary to primary hypothyroidism.

Authors:  N A Samaan; B M Osborne; B Mackay; M E Leavens; T M Duello; N S Halmi
Journal:  J Clin Endocrinol Metab       Date:  1977-11       Impact factor: 5.958

2.  Hyperthyroidism due to thyrotropin-producing pituitary chromophobe adenoma.

Authors:  C R Hamilton; L C Adams; F Maloof
Journal:  N Engl J Med       Date:  1970-11-12       Impact factor: 91.245

Review 3.  Inappropriate secretion of thyroid-stimulating hormone.

Authors: 
Journal:  Ann Intern Med       Date:  1981-09       Impact factor: 25.391

4.  The effects of tetraiodothyroacetic and triiodothyroacetic acids on thyroid function in euthyroid and hyperthyroid subjects.

Authors:  A G Burger; D Engler; C Sakoloff; V Staeheli
Journal:  Acta Endocrinol (Copenh)       Date:  1979-11

5.  Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3,5,3'-triiodothyroacetic acid (TRIAC).

Authors:  P Beck-Peccoz; G Piscitelli; M G Cattaneo; G Faglia
Journal:  J Endocrinol Invest       Date:  1983-06       Impact factor: 4.256

6.  Hyperthyroidism due to a thyrotrophin-secreting microadenoma.

Authors:  H A Kellett; A H Wyllie; B A Dale; J J Best; A D Toft
Journal:  Clin Endocrinol (Oxf)       Date:  1983-07       Impact factor: 3.478

Review 7.  Syndromes of thyroid hormone resistance.

Authors:  S Refetoff
Journal:  Am J Physiol       Date:  1982-08

8.  Familial hyperthyroidism due to inappropriate thyrotropin secretion successfully treated with triiodothyronine.

Authors:  A Rösler; Y Litvin; C Hage; J Gross; E Cerasi
Journal:  J Clin Endocrinol Metab       Date:  1982-01       Impact factor: 5.958

9.  The spectrum of inappropriate pituitary thyrotropin secretion associated with hyperthyroidism.

Authors:  H Gharib; P C Carpenter; B W Scheithauer; F J Service
Journal:  Mayo Clin Proc       Date:  1982-09       Impact factor: 7.616

10.  Hyperthyroidism due to a TSH secreting pituitary adenoma: case report, treatment and evidence for adenoma TSH by morphological and cell culture studies.

Authors:  K Mashiter; S Van Noorden; R Fahlbusch; H Fill; K Skrabal
Journal:  Clin Endocrinol (Oxf)       Date:  1983-05       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.